Related Experiment Video
Updated: May 6, 2026

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
Published on: July 21, 2017
Autophagy contributes to apoptosis in A20 and EL4 lymphoma cells treated with fluvastatin
Xu-Feng Qi1, Dong-Heui Kim, Kyu-Jae Lee
1Key Laboratory for Regenerative Medicine of Ministry of Education, Ji Nan University School of Life Science and Technology, Guangzhou, 510632, People's Republic of China. qixufeng@jnu.edu.cn.
Abstract:
Convincing evidence indicates that statins stimulate apoptotic cell death in several types of proliferating tumor cells in a cholesterol-lowering-independent manner. However, the relationship between apoptosis and autophagy in lymphoma cells exposed to statins remains unclear. The objective of this study was to elucidate the potential involvement of autophagy in fluvastatin-induced cell death of lymphoma cells. We found that fluvastatin treatment enhanced the activation of pro-apoptotic members such as caspase-3 and Bax, but suppressed the activation of anti-apoptotic molecule Bcl-2 in lymphoma cells including A20 and EL4 cells. The process was accompanied by increases in numbers of annexin V alone or annexin V/PI double positive cells. Furthermore, both autophagosomes and increases in levels of LC3-II were also observed in fluvastatin-treated lymphoma cells. However, apoptosis in fluvastatin-treated lymphoma cells could be blocked by the addition of 3-methyladenine (3-MA), the specific inhibitor of autophagy. Fluvastatin-induced activation of caspase-3, DNA fragmentation, and activation of LC3-II were blocked by metabolic products of the HMG-CoA reductase reaction, such as mevalonate, farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP). These results suggest that autophagy contributes to fluvastatin-induced apoptosis in lymphoma cells, and that these regulating processes require inhibition of metabolic products of the HMG-CoA reductase reaction including mevalonate, FPP and GGPP.
Insights
Statins like fluvastatin induce lymphoma cell death by promoting apoptosis and autophagy. Inhibiting autophagy blocks this cell death, suggesting autophagy contributes to statin-induced apoptosis in lymphoma.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Statins are known to induce apoptosis in various cancer cells independently of cholesterol reduction.
- The interplay between apoptosis and autophagy in statin-treated lymphoma cells is not well understood.
Purpose of the Study:
- To investigate the role of autophagy in fluvastatin-induced apoptosis of lymphoma cells.
- To identify the specific molecular pathways involved in fluvastatin's effects on lymphoma cells.
Main Methods:
- Lymphoma cell lines (A20, EL4) were treated with fluvastatin.
- Apoptosis was assessed by measuring caspase-3, Bax, Bcl-2 levels, and annexin V/PI staining.
- Autophagy was evaluated by observing autophagosomes and LC3-II levels.
- The effect of autophagy inhibitor 3-methyladenine (3-MA) was tested.
- The role of HMG-CoA reductase metabolites (mevalonate, FPP, GGPP) was examined.
Main Results:
- Fluvastatin enhanced pro-apoptotic markers (caspase-3, Bax) and reduced anti-apoptotic marker (Bcl-2).
- Fluvastatin treatment increased annexin V positive cells and induced autophagosomes with elevated LC3-II levels.
- Autophagy inhibition with 3-MA blocked fluvastatin-induced apoptosis.
- Mevalonate, FPP, and GGPP reversed fluvastatin-induced apoptosis, caspase-3 activation, DNA fragmentation, and LC3-II activation.
Conclusions:
- Autophagy plays a significant role in fluvastatin-induced apoptosis in lymphoma cells.
- The apoptotic and autophagic effects of fluvastatin are dependent on the inhibition of HMG-CoA reductase metabolic products, including mevalonate, FPP, and GGPP.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
12:55Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Apoptosis